A Bayesian Characterization of Relative Entropy
John C. Baez, Tobias Fritz

TL;DR
This paper provides a new Bayesian-inspired categorical characterization of relative entropy, showing it as the unique measure satisfying certain functorial and optimality conditions within a probability-based category.
Contribution
It introduces a novel categorical framework for relative entropy, independent of previous characterizations, inspired by Petz's work, and highlights its uniqueness under specific functorial properties.
Findings
Relative entropy is characterized as a unique functor under certain conditions.
The framework uses a category with probability distributions and measure-preserving functions.
The characterization is independent of earlier approaches and based on categorical and Bayesian concepts.
Abstract
We give a new characterization of relative entropy, also known as the Kullback-Leibler divergence. We use a number of interesting categories related to probability theory. In particular, we consider a category FinStat where an object is a finite set equipped with a probability distribution, while a morphism is a measure-preserving function together with a stochastic right inverse . The function can be thought of as a measurement process, while s provides a hypothesis about the state of the measured system given the result of a measurement. Given this data we can define the entropy of the probability distribution on relative to the "prior" given by pushing the probability distribution on forwards along . We say that is "optimal" if these distributions agree. We show that any convex linear, lower semicontinuous functor from FinStat to the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsReceptor Mechanisms and Signaling · Statistical Mechanics and Entropy · Computational Drug Discovery Methods
